Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
- DOI
- 10.1016/s0360-3016(00)01546-7
- Published
- 2001 May 1
- Container
- International journal of radiation oncology, biology, physics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0360-3016-00-01546-7,
title = {Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.},
author = {Jeremic B and Shibamoto Y and Acimovic L and Milicic B and Milisavljevic S and Nikolic N and Dagovic A and Aleksandrovic J and Radosavljevic-Asic G},
year = {2001},
journal = {International journal of radiation oncology, biology, physics},
doi = {10.1016/s0360-3016(00)01546-7},
url = {https://doi.org/10.1016/s0360-3016(00)01546-7}
}RIS
TY - JOUR TI - Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial. AU - Jeremic B AU - Shibamoto Y AU - Acimovic L AU - Milicic B AU - Milisavljevic S AU - Nikolic N AU - Dagovic A AU - Aleksandrovic J AU - Radosavljevic-Asic G PY - 2001 JO - International journal of radiation oncology, biology, physics DO - 10.1016/s0360-3016(00)01546-7 UR - https://doi.org/10.1016/s0360-3016(00)01546-7 ER -
APA
B, J., Y, S., L, A., B, M., S, M., N, N., A, D., J, A., & G, R. (2001). Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.. International journal of radiation oncology, biology, physics. https://doi.org/10.1016/s0360-3016(00)01546-7
Source records
- pubmed · retrieved 2026-09-25T15:04:46.055Z